Orbital cellulitis: Difference between revisions

No edit summary
 
(20 intermediate revisions by 8 users not shown)
Line 5: Line 5:


==Clinical Features==
==Clinical Features==
[[File:Proptosis 2014-10-28 12-32.jpg|thumb|Orbital Cellulitis with retrobulbar hematoma and proptosis]]
[[File:Proptosis 2014-10-28 12-32.jpg|thumb|Orbital [[Cellulitis]] with retrobulbar hematoma and proptosis]]
#Swelling and erythema of tissues surrounding the orbit AND:
[[File:PMC2892128 MEAJO-17-134-g001.png|thumb|Left orbital cellulitis secondary to penetrating dog bite.]]
##Proptosis
*Swelling and erythema of tissues surrounding the orbit AND:
##Chemosis
**[[Proptosis]]
##Globe displacement
**[[red eye|Chemosis]]
##Limitation of eye movements
**Globe displacement
##Double vision
**Limitation of EOM
##Decreased visual acuity
**Pain with eye movements
**[[diplopia|Double vision]]
**[[vision loss|Decreased visual acuity]]
**Possible [[third nerve palsy|CN III]], [[trochlear nerve palsy|IV]], [[abducens nerve palsy|VI palsies]] in cases of cavernous sinus involvement


==Diagnosis==
===Complications===
#CT Orbit with IV contrast
*Orbital abscess
##Findings c/w orbital cellulitis:
**Patients tend to have severe proptosis, globe displacement, and appear systemically ill
###Proptosis
**May be clinically indistinguishable from orbital cellulitis; requires CT
###Inflammation of ocular muscles
*[[Meningitis]]
###Subperiosteal or orbital abscess
*[[Cavernous sinus thrombosis]]
*Frontal bone [[osteomyelitis]]
*[[Subdural empyema]]
*[[Epidural abscess]]
*[[Brain abscess]]


==Differential Diagnosis==
==Differential Diagnosis==
{{Periorbital swelling DDX}}
{{Periorbital swelling DDX}}


==Treatment==
==Evaluation==
[[File:PMC2892128 MEAJO-17-134-g002.png|thumb|Left medial subperiosteal abscess with associated ethmoid sinusitis.]]
*CT Orbit with IV contrast
**Proptosis
**Inflammation of ocular muscles
**Subperiosteal or orbital abscess
 
==Management==
===Antibiotics===
===Antibiotics===
{{Orbital Cellulitis Antibiotics}}
{{Orbital Cellulitis Antibiotics}}
*Consider [[fungal infections]] with [[mucormycosis|mucor]] or [[aspergillus]] in DM or immunocompromised<ref>Farooq AV et al. Fungal Orbital Cellulitis: Presenting Features, Management and Outcomes at a Referral Center. Orbit. Vol. 34 , Iss. 3,2015.</ref>
**[[Amphotericin B]] IV 0.3 mg/kg/day initially
**May require supplemental intra-orbital catheter delivery


===Consults===
===Consults===
*Ophthalmology consult to arrange close followup
*Ophthalmology consult to arrange close follow-up


==Disposition==
==Disposition==
*Admit
*Admit
==Complications==
#Orbital Abscess
##Pts tend to have severe proptosis, globe displacement, and appear systemically ill
##May be clinically indistinguishable from orbital cellulitis; requires CT
#Meningitis
#Cavernous sinus thrombosis
#Frontal bone osteomyelitis
#Subdural empyema
#Epidural abscess
#Brain abscess


==See Also==
==See Also==
*[[Periorbital vs Orbital Cellulitis]]
*[[Periorbital Swelling]]
*[[Periorbital Swelling]]
*[[Periorbital Cellulitis]]
*[[Periorbital Cellulitis]]


==Source==
==References==
*UpToDate
<references/>
*Tintinalli
 
[[Category:ID]]
[[Category:ID]]
[[Category:Ophtho]]
[[Category:Ophthalmology]]

Latest revision as of 00:11, 27 February 2021

Background

Periorbital vs orbital cellulitis

Clinical Features

Orbital Cellulitis with retrobulbar hematoma and proptosis
Left orbital cellulitis secondary to penetrating dog bite.

Complications

Differential Diagnosis

Periorbital swelling

Proptosis

No proptosis

Lid Complications

Other

Evaluation

Left medial subperiosteal abscess with associated ethmoid sinusitis.
  • CT Orbit with IV contrast
    • Proptosis
    • Inflammation of ocular muscles
    • Subperiosteal or orbital abscess

Management

Antibiotics

Vancomycin 15-20mg/kg IV BID + (one of the following)

Consults

  • Ophthalmology consult to arrange close follow-up

Disposition

  • Admit

See Also

References

  1. Farooq AV et al. Fungal Orbital Cellulitis: Presenting Features, Management and Outcomes at a Referral Center. Orbit. Vol. 34 , Iss. 3,2015.